Bridging the Biomarker Gap
How to bring better diagnostic tests to the market to benefit patients.
Rainer Bischoff |
Biomarker discovery and validation relies heavily on reproducible and robust analytical methodology. Separation science and notably high performance liquid chromatography (HPLC) are essential and efforts spent in developing more efficient and robust HPLC stationary phases, together with advanced mass spectrometers, have made modern biomarker research possible. Given that many clinical biomarkers are proteins, advances in protein bioanalysis and proteomics have also been critical in driving the biomarker field forward. Many new biomarker candidates are proposed for various diseases every week – but often from small-scale studies lacking statistical power.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.